155 Results for "

modifiers

" in MedChemExpress (MCE) Product Catalog:
Products (155)

155 Results for "modifiers" in MCE Product Catalog:

62
62 Publications Verification
Cat. No.: HY-B0180
CAS No.: 99011-02-6
Synonyms: R 837
Imiquimod (R 837), an immune response modifier, is a selective toll like receptor 7 (TLR7) agonist. Imiquimod exhibits antiviral and antitumor effects in vivo. Imiquimod can be used for the research of external genital, perianal warts, cancer and COVID-19 .
loading...
    loading...
62
62 Publications Verification
Cat. No.: HY-B0180A
CAS No.: 99011-78-6
Synonyms: R 837 hydrochloride
Imiquimod hydrochloride (R 837 hydrochloride), an immune response modifier, is a selective toll like receptor 7 (TLR7) agonist. Imiquimod hydrochloride exhibits antiviral and antitumor effects in vivo. Imiquimod hydrochloride can be used for the research of external genital, perianal warts, cancer and COVID-19 .
loading...
    loading...
62
62 Publications Verification
Cat. No.: HY-B0180B
CAS No.: 896106-16-4
Imiquimod maleate (R 837 maleate), an immune response modifier, is a selective toll like receptor 7 (TLR7) agonist. Imiquimod maleate exhibits antiviral and antitumor effects in vivo. Imiquimod maleate can be used for the research of external genital, perianal warts, cancer and COVID-19 .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-109101
CAS No.: 1825352-65-5
Purity:  99.58%
Synonyms: RG7916; RO7034067
Target:  

DNA/RNA Synthesis

Research Areas:  

Neurological Disease

Risdiplam (RG7916) is an orally administered, centrally and peripherally distributed SMN2 pre-mRNA splicing modifier that increases survival motor neuron (SMN) protein levels .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-101792
CAS No.: 1449598-06-4
Purity:  99.88%
Synonyms: RO6885247
Target:  

DNA/RNA Synthesis

Research Areas:  

Others

RG7800 is a SMN2 splicing modifier. RG7800 has the potential for spinal muscular atrophy treatment.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-122575
CAS No.: 4431-00-9
Purity:  ≥92.0%
Aurintricarboxylic acid is a nanomolar-potency, allosteric antagonist with selectivity towards αβ-methylene-ATP-sensitive P2X1Rs and P2X3Rs, with IC50s of 8.6 nM and 72.9 nM for rP2X1R and rP2X3R, respectively . Aurintricarboxylic acid is a potent anti-influenza agent by directly inhibiting the neuraminidase . Aurintricarboxylic acid is an inhibitor of topoisomerase II and apoptosis . Aurintricarboxylic acid is a selective inhibitor of the TWEAK-Fn14 signaling pathway . Aurintricarboxylic acid also acts as a cystathionine-lyase (CSE) inhibitor with an IC50 of 0.6 μM . Aurintricarboxylic acid is a modifier of miRNAs that regulate miRNA function, with an IC50 of 0.47 µM .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-W011950
CAS No.: 52417-22-8
Target:  

DNA/RNA Synthesis

Research Areas:  

Others

Acridin-9-amine (9-Aminoacridine) hydrochloride hydrate is a mutagen and DNA modifier. Acridin-9-amine hydrochloride hydrate induces mutagenic lesions during DNA replication .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-10913A
CAS No.: 943133-81-1
Purity:  99.49%
Synonyms: GAP-134 Hydrochloride; ZP 1609 Hydrochloride
Target:  

Gap Junction Protein

Research Areas:  

Cardiovascular Disease

Danegaptide Hydrochloride (GAP-134 Hydrochloride) is a potent, selective and orally active gap-junction modifier with an antiarrhythmic effect .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-18593
CAS No.: 104723-60-6
Synonyms: 6-O-alpha-D-Maltosyl-beta-cyclodextrin
Mal-β-CD is a cellular cholesterol modifier which can form soluble inclusion complex with cholesterol.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-13619
CAS No.: 131179-95-8
Purity:  99.94%
Synonyms: RSR13
Target:  

Hemoglobin

Research Areas:  

Infection Cancer

Efaproxiral (RSR13) is a haemoglobin (Hb) synthetic allosteric modifier. Efaproxiral decreases Hb-oxygen (O2) binding affinity and enhances oxygenation of hypoxic tumours during radiation therapy .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-13619A
CAS No.: 170787-99-2
Purity:  99.90%
Synonyms: RSR13 sodium
Target:  

Hemoglobin

Research Areas:  

Infection Cancer

Efaproxiral (RSR13) sodium is a haemoglobin (Hb) synthetic allosteric modifier. Efaproxiral sodium decreases Hb-oxygen (O2) binding affinity and enhances oxygenation of hypoxic tumours during radiation therapy .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-100360
CAS No.: 1502816-23-0
Purity:  ≥98.0%
Research Areas:  

Cancer

MS049, a chemical probe, is a potent, selective, and cell-active dual inhibitor of PRMT4 and PRMT6 with IC50s of 34 nM and 43 nM, respectively. MS049 reduces levels of Med12me2a and H3R2me2a in HEK293 cells. MS049 is not toxic and does not affect the growth of HEK293 cells .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-153182
CAS No.: 1628799-51-8
Purity:  99.37%
Target:  

Drug Derivative

Research Areas:  

Cardiovascular Disease

GBT1118 is a potent and orally active allosteric modifier of hemoglobin oxygen affinity. GBT1118 increases tolerance to severe hypoxia .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B1008A
CAS No.: 138-84-1
Synonyms: PABA potassium; p-Aminobenzoic acid potassium
4-Aminobenzoic acid (PABA) potassium is a modifier of catecholamine oxidation reactions. 4-Aminobenzoic acid potassium is promising for research of Parkinson's disease and hypertension .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-109101S
Purity:  98.88%
Risdiplam-d4 is deuterium labeled Risdiplam. Risdiplam (RG7916) is an orally administered, centrally and peripherally distributed SMN2 pre-mRNA splicing modifier that increases survival motor neuron (SMN) protein levels .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-134594
CAS No.: 2416910-69-3
Purity:  99.55%
Target:  

E1/E2/E3 Enzyme

Research Areas:  

Cancer

SENP1-IN-1 is a specific deSUMOylation protease 1 (SENP1) inhibitor extracted from patent CN110627860, Compound 29. SENP1-IN-1 is developed for tumor radiosensitivity enhancement .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-15929
CAS No.: 14348-40-4
Synonyms: 2,4,6-Tribromo-3-hydroxybenzoic acid
TBHBA (2,4,6-Tribromo-3-hydroxybenzoic acid) is a chemical colorimetric agent and nanomaterial surface modifier. TBHBA can react with some oxidants (such as H2O2) to generate high-absorbance quinoneimine dyes, which enhance the sensitivity of HDL cholesterol enzymatic determination. TBHBA can be used as a bromine-containing coupling agent to modify the surface of silica nanoparticles through esterification reaction. Thereby, organic flame retardant groups are introduced to improve the thermal stability and flame retardant properties of nanocomposites. TBHBA can be used in clinical biochemical testing (such as serum lipoprotein analysis) and the preparation of flame-retardant polymer nanocomposites .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B2221B1
CAS No.: 9004-62-0
Research Areas:  

Others

Hydroxyethyl cellulose, Viscosity(2%):150mPa.s is a class of nonionic cellulose ether gel-forming polymers with pH-independent drug release properties. When used as a tablet coating, Hydroxyethyl cellulose, Viscosity(2%):150mPa.s regulates the water permeation rate, thereby altering the drug release lag time; the higher the viscosity, the longer the drug release lag time. When used as a hydrogel thickener, it increases the dynamic viscosity of the system. Hydroxyethyl cellulose, Viscosity(2%):150mPa.s can be used in organic synthesis-related research, such as pharmaceutical excipients, hydrogel thickeners, etc.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-W127512
CAS No.: 546-18-9
Target:  

Drug Intermediate

Research Areas:  

Others

5β-Cholanic acid is a hydrophobic modifier used to modify polymer carriers. 5β-Cholanic acid can improve the acid stability, cell penetration efficiency and drug sustained release ability of nanocarriers, and optimize the oral effectiveness of delivered molecules. 5β-Cholanic acid can covalently bind to Glycol chitosan (GC) to form a GC-CA conjugate, which optimizes the hydrophobic anchoring ability of nanoparticles and enables them to be stably adsorbed on the surface of PLGA nanoparticles. Such nanoparticles can resist dissociation in the gastric acid environment and maintain positive charge to enhance endocytic uptake by intestinal epithelial cells (such as Caco-2 cells). 5β-Cholanic acid can be used in the development of drug delivery systems .
loading...
    loading...
Cat. No.: HY-W015114
CAS No.: 63512-50-5
Synonyms: (S)-2-Hydroxyglutaric acid disodium
L-2-Hydroxyglutaric acid disodium is an epigenetic modifier and putative oncometabolite in renal cancer. L-2-Hydroxyglutaric acid disodium can inhibit histone demethylases and hence promote histone methylation . L-2-Hydroxyglutaric acid inhibits mitochondrial creatine kinase (Mi-CK) activity with Km and Ki of 2.52 mM and 11.13 mM, respectively .
loading...
    loading...